The critics of Bionano (NASDAQ:BNGO) stock are ignoring and/or severely underestimating developments involving its DNA mapping tool, Saphyr. Source: Natali_ Mis/ShutterStock.com Specifically, there is ...
Hosted on MSN
Bionano Genomics earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call
Bionano Genomics, Inc. BNGO will release earnings results for its fourth quarter, after the closing bell on Monday, March 23. Analysts expect the San Diego, California-based company to report a ...
Bionano Genomics Inc (BNGO) reports strong revenue growth and operational efficiencies, but faces supply constraints and leadership transitions.
Fintel reports that on November 24, 2025, HC Wainwright & Co. maintained coverage of Bionano Genomics (NasdaqCM:BNGO) with a Buy recommendation. As of November 17, 2025, the average one-year price ...
Image source: The Motley Fool. Management signaled a business model shift prioritizing increased consumable and software usage among routine users rather than aggressive expansion of the installed ...
Bionano Genomics, Inc. reports earnings inline with expectations. Reported EPS is $-2.475 EPS, expectations were $-2.475. Operator: Good day, and welcome to the Bionano Genomics, Inc. Fourth Quarter ...
Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Kelly Gura from ...
Bionano Genomics, Inc. beats earnings expectations. Reported EPS is $-1.59292, expectations were $-1.81. Operator: Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results